FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE4213.6556.8 (+1.37 %)

PREV CLOSE (Rs.) 4156.85

OPEN PRICE (Rs.) 4132.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 275

TODAY'S LOW / HIGH (Rs.)4132.00 4299.00

52 WK LOW / HIGH (Rs.)3950.5 5394

NSE4213.7063.7 (+1.53 %)

PREV CLOSE( Rs. ) 4150.00

OPEN PRICE (Rs.) 4180.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3831

TODAY'S LOW / HIGH(Rs.) 4122.10 4301.60

52 WK LOW / HIGH (Rs.)3975 5357

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

11.52

Dividend Yield(%)

1.78

TTM EPS (Rs.)

115.50

P/E Ratio

36.48

Book Value (Rs.)

151.07

Face Value (Rs.)

MCap (Rs. in Mn)

97042.98

Price/Earning (TTM)

34.76

Price/Sales (TTM)

10.22

Price/Book (MRQ)

27.89

PAT Margin (%)

26.08

ROCE (%)

98.11

Incorporation Year : 10-05 2023

Management Info :

Amit Jain - Chairman Himanshu Bakshi - Managing Director

Registered Office :

Address : Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone : 022 45288855

Email : igrc.schil@sanofi.com

Website : www.sanofi.in

Registrars Details :

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

05May Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that the Exchange has rece..

28Apr Sanofi Consumer Healthcare India infor
With reference to its letter dated 23rd April 2026 informing its Board M..

27Mar Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that it enclosed transcrip..

Financials

	QTR Jun 26	ANNUAL 25
Net Profit	688	2401
Gross Profit	919	3203
Operating Profit	956	3274
Net Sales	2357	8784

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Laboratories (BSE)

9269.00 (2.42%)

M.Cap (Rs. in Cr)246062.83

Glenmark Pharma. (BSE)

2517.40 (2.50%)

M.Cap (Rs. in Cr)71047.24

Kwality Pharma (BSE)

3310.25 (1.37%)

M.Cap (Rs. in Cr)3434.78

Haleos Labs (BSE)

1542.00 (2.97%)

M.Cap (Rs. in Cr)466.19

Shareholding Pattern

	PROMOTERS	71.27%
	MUTUAL FUNDS/UTI	13.01%
	NON-INSTITUTION	8.27%
	FI/BANKS/INSURANCE	4.84%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Bajaj Finserv Healt...

2.17

Sundaram Small Cap ...

1.92

Bajaj Finserv Balan...

1.59

Nippon India Pharma...

1.42

ICICI Pru Smallcap ...

1.33

Aditya Birla SL Sma...

1.28

Aditya Birla SL Pha...

1.27

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

SANOFI CONSUMER HEALTHCARE INDIA LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives